盐酸替罗非班对急性心肌梗死急诊经皮冠状动脉介入治疗的临床价值

Abstract
Figure/Table
References (18)
Related Citation (1)

Download: PDF (857 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate clinical value of Tirofiban Hydrochloride in emergency percutaneous coronary intervention in patients with acute myocardial.Methods 112 patients with acute myocardial treated emergency percutaneous coronary intervention in our hospital from August 2014 to August 2016 were selected and divided into the control group and the observation group according to random number table method,56 cases in each group.The control group was treated with conventional treatment,the observation group was given combination with Tirofiban Hydrochloride.The condition of blood flow,cardiac function,indicator repeat time,adverse events were compared between two groups.Results After treatment,TIMI blood flow of infarct related vessels and cardiac function improved in the two groups (P＜0.05).TIMI blood flow of infarct related vessels and cardiac function improvement in the observation group after treatment were better than those in the control group (P＜0.05).Recovery time of ST segment,occurrence time of myocardial enzyme peak in the observation group were earlier than those in the control group (P＜0.05).Hospitalization time in the observation group was less than that in the control group (P＜0.05).The incidence of adverse events (intraoperative slow flow,reperfusion arrhythmia,bleeding,thrombocytopenia) in the observation group were lower than those in the control group (P＜0.05).Conclusion As emergency percutaneous coronary intervention in patients with acute myocardial,tirofiban hydrochloride can improve TIMI blood flow and cardiac function,which can also reduce the risk of adverse events.

Key words： Tirofiban Hydrochloride Acute myocardial Percutaneous coronary intervention

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	FENG Ji LIU Juan-feng YAN Mei-jun

Cite this article:

FENG Ji LIU Juan-feng YAN Mei-jun. Clinical value of Tirofiban Hydrochloride in emergency percutaneous coronary intervention in patients with acute myocardial[J]. 中国当代医药, 2017, 24(36): 108-110转125.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I36/108

[1]	苏懿，王磊，张敏州，等.急性心肌梗死的流行病学研究进展[J].中西医结合心脑血管病杂志，2012，10（4）：467-469.
[2]	刘杰，陈挺，余云华，等.上海市杨浦区2007～2014年急性心肌梗死空间数据探索性分析[J].中国循证心血管医学杂志，2016，8（4）：464-467.
[3]	李雁君，李针，刘超，等.尿激酶与经皮冠状动脉介入术治疗老年急性心肌梗死的临床研究[J].中国临床药理学杂志，2015，31（3）：163-165.
[4]	耿旭影，徐明明，牛鹏飞，等.经桡动脉行急诊经皮冠状动脉介入术治疗急性心肌梗死的护理[J].安徽医药，2016， 20（2）：388-389.
[5]	中华医学会心血管病学分会，中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志，2015，43（5）：380-393.
[6]	王佳玲，郑逸，阮海东，等.冠心病PTCA术后临床心功能分级与心脏局部及整体功能相关性分析[J].东南大学学报（医学版），2016，35（6）：943-946.
[7]	钟斌，刘增长，苏立，等.临床风险积分、心肌梗死溶栓试验血流分级和联合风险积分对急性冠状动脉综合征预后评估价值的比较[J].中华心血管病杂志，2008，36（1）：30-35.
[8]	舒晓蓉，谢双伦，林永青，等.急性心肌梗死患者血清IL-18升高参与斑块破裂的机制[J].中国动脉硬化杂志，2014， 22（9）：934-938.
[9]	于海丽.急性心肌梗死后心脏破裂的发病机制[J].医学综述，2015，21（2）：252-254，259.
[10]	李厚荣，何娟，杜国伟，等.心率减速力对急性心肌梗死患者的预警研究[J].江苏实用心电学杂志，2015，24（4）：283-286.
[11]	黄东.心电图在急性心肌梗死超急性期诊断中的应用[J].江苏实用心电学杂志，2016，25（4）：285-287.
[12]	卢健棋，何贵新，潘朝锌，等.安心颗粒联合替罗非班对急性心肌梗死PCI术后患者临床疗效的研究[J].中国中药杂志，2014，39（5）：920-924.
[13]	王永刚，齐婧，郑刚，等.双参通冠胶囊治疗急性心肌梗死直接PCI术后患者的临床观察[J].中国中西医结合杂志，2012，32（12）：1602-1606.
[14]	毛幼林，黄琼，王瑞敏，等.血栓抽吸联合替罗非班及硝普钠对急性心肌梗死患者无复流的影响[J].中国现代医生，2016，54（7）：25-28.
[15]	彭瑜，张钲，白明，等.平均血小板体积和血小板聚集率与急性冠状动脉综合征患者支架内血栓的相关性研究[J].中国介入心脏病学杂志，2015，23（2）：75-79.
[16]	许香俊.抗血小板药物的研究进展[J].天津药学，2016，28（3）：66-70.
[17]	冯俊，李胜友，钱福东，等.血栓抽吸导管联合盐酸替罗非班在急性心肌梗死患者介入治疗中的临床应用[J].安徽医药，2013，17（2）：293-295.
[18]	曲虹，丁美精，方诗忠，等.血栓抽吸盐酸替罗非班在急性心肌梗死急诊介入治疗中的临床应用[J].安徽医学，2015，36（3）：307-309.